MicroRNA-126 inhibits invasion in bladder cancer via regulation of ADAM9.

Br J Cancer · 2014 · PMC4056059 · PMID 24823697

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a clear trendno p-value reported

Although not statistically significant, there is a clear trend that ADAM9 expression predicts a worse outcome for DSS, where an ADAM9-positive phenotype corresponded to a median DSS of 52.5 months (95% CI 33.1–71.9 months), whereas an ADAM9-negative phenotype did not reach median DSS ( P <0.130) after a follow-up of 76.1 months ( Figure 5D ).

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.